2021
SJR Q1
JCR Q2 · 3,2
10 matched articles
SCIE
Journal detail
Discovery Medicine
- Publisher
- Solariz, Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1539650919447930
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,966
- Quartile Q1
- H-Index 68
- Cites/doc 0
- Docs (3y) 21
- Cites (3y) 107
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,2
- 5Y JIF 2,9
- JCI 0,55
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q1
Areas
- Medicine
WoS categories
- Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | — | Q2 | — | 3,2 | 2,9 | 0,55 | Q3 | — |
| 2024 | — | Q3 | — | 2,1 | 2,2 | 0,48 | Q3 | — |
| 2023 | — | Q3 | — | 2 | 2,8 | 0,43 | Q3 | — |
| 2022 | — | Q4 | — | 1,4 | 3 | 0,54 | Q3 | — |
| 2021 | Q1 | Q3 | 0,966 | 3,2 | 3,1 | 0,69 | Q2 | 68 |
| 2020 | Q2 | Q3 | 0,913 | 3 | 2,7 | 0,73 | Q2 | 68 |
| 2019 | Q2 | Q3 | 0,807 | 2,2 | 2,3 | 0,77 | Q2 | 68 |
| 2018 | — | Q3 | — | 1,9 | 2,4 | 0,84 | Q2 | — |
| 2017 | Q1 | Q3 | 1,077 | 2,4 | 2,8 | 1,02 | Q2 | 68 |
| 2016 | Q1 | Q3 | 1,194 | 2,4 | 3 | — | — | 68 |
| 2015 | Q1 | Q2 | 1,577 | 3,4 | 3,1 | — | — | 68 |
| 2014 | Q1 | Q2 | 1,839 | 3,6 | — | — | — | 68 |
| 2013 | Q1 | Q2 | 1,46 | 3,5 | — | — | — | 68 |
| 2012 | Q1 | Q2 | 1,148 | 3 | — | — | — | 68 |
| 2011 | Q2 | — | 0,775 | — | — | — | — | 68 |
| 2010 | Q3 | — | 0,325 | — | — | — | — | 68 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 90/191 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 117/195 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 122/189 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 117/136 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 93/139 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 89/140 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 94/139 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 92/136 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 77/133 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 68/128 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 35/124 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 31/123 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 34/124 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 43/121 |